Interleukin-1 and tumor necrosis factora modulators; syntheses of such modulators and methods of using such modulators

Details for Australian Patent Application No. 2006276274 (hide)

Owner Nereus Pharmaceuticals, Inc. The Regents of the University of California

Inventors Macherla, Venkat Rami Reddy; Chao, Ta-Hsiang; Theodorakis, Emmanuel A.; Suh, Young Ger; Palladino, Michael A.

Agent Fisher Adams Kelly

Pub. Number AU-B-2006276274

PCT Pub. Number WO2007/015757

Priority 60/734,679 07.11.05 US; 60/701,932 21.07.05 US; 60/785,223 22.03.06 US; 60/734,590 07.11.05 US; 60/749,542 12.12.05 US

Filing date 14 July 2006

Wipo publication date 8 February 2007

Acceptance publication date 29 March 2012

International Classifications

C07C 233/58 (2006.01) Carboxylic acid amides

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61P 35/00 (2006.01) Antineoplastic agents

C07C 49/557 (2006.01) Ketones

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/015757 Priority application(s): WO2007/015757

14 August 2008 Assignment before Grant

  Nereus Pharmaceuticals, Inc. The application has been assigned to Nereus Pharmaceuticals, Inc.; The Regents of the University of California

29 March 2012 Application Accepted

  Published as AU-B-2006276274

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006276278-Medical devices coated with a fast dissolving biocompatible coating

2006276272-Child-resistant compact for blister card products